TUESDAY, March 29, 2022 (HealthDay News) — Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS). In an analysis of Amylyx Pharmaceuticals’ drug, known for now onlyContinue Reading

MONDAY, March 28, 2022 (HealthDay News) — Been vaccinated? Already had COVID? New research shows that your chances of winding up in the hospital if you get a breakthrough infection are practically nil. In the study, scientists looked at more than 106,000 hospitalized primary care patients, aged 18 and older,Continue Reading

FRIDAY, March 25, 2022 (HealthDay News) — Psilocybin, the psychedelic substance in “magic” mushrooms, is generating lots of interest as a potential treatment for a host of mental ills, but new research warns there is little data on how it might interact with more traditional psychiatric medications. “There’s a majorContinue Reading